Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 611

Ageing in spurts

Recently I’ve focused a lot on aspects of longevity. A blog post on explaining the often-misused term 'life expectancy', then one on whether our lifespan is influenced more by genetics or by lifestyle, then what our biological age (as opposed to our chronological age) depends on.  And now (the final one, I promise!) one on the fact that our biological age itself doesn’t change at a uniform rate, but seems to increase in spurts at specific times in our lives.

A quick reminder: our chronological age is how old we are in terms of how long it has been since we were born, whereas our biological age relates to how much the life systems in our body have aged. And since different systems in our bodies have aged at different rates and to different extents, our so-called biological age is just a rough shorthand for the average of how old our body systems seem to be. For some our biological age is less than our chronological age, for others our biological age exceeds our chronological age.

The gap between the two doesn’t stay constant. It seems that there are particular times when our biological clock accelerates.

OK, now to one recent study and its conclusions.

The study involved 108 participants aged between 25 and 75, resident in California. They were followed for varying periods of time, the longest being almost 7 years, though most of them were followed for a bit less than 2 years. There were, in all, more than 5,000 biological samples taken (oral, blood and stool samples, for sure: I couldn’t understand what else was involved), hence more than 100,000 biological features were measured, resulting in more than 200 billion data points.

Now the conclusions.

The molecules and microbes that they studied didn’t change uniformly over time. When the researchers looked at the results more closely (a colossal amount of analysis was involved), the rates of changed showed a fair amount of clustering relative to participants’ ages. (And as you can guess, the effects of many factors, for example female menopause, had to be eliminated. Insulin-sensitivity and ethnicity were other causal characteristics eliminated.) Specifically, then, they identified two major waves of ageing-related molecular changes across the human lifespan.

Explaining them, a science reporter for the New York Times says that the study found that people seemed to age more rapidly around age 44, and again around age 60. The clusters of changes in the first ageing spike (around age 44) appeared to be mostly related to fat and alcohol metabolism, as well as to muscle function. The second spike (around age 60), while also involving muscle function, appeared to be mostly related to immune dysfunction. (The study’s authors note that a previous study reported crests at ages 34, 60 and 78, but their data didn’t include anyone older than 75.)

A study coauthor said that the first spike could help explain why people seem to have more trouble processing alcohol starting in their 40s, while the second spike could help explain why people become more prone to illness in their 60s. (This is consistent with a recent study on the ageing of mice, which suggested that there were sudden chemical modifications to their DNA, one in early-to-mid life, the other in mid-to-late life.)

I notice that they didn’t comment on muscle function, though both spikes were specifically associated with muscle function, and at my age that’s an important feature of my health.

Fascinating! So if you ever thought that you seemed to age more rapidly in a particular year or period of your life, now you’ll know that this is not unexpected.

But I’m not going to get too excited about all of this, and I don’t think we should focus too closely at ages 44 and 60. (For example, age 44 isn’t really at all close to the age 34 that the previous study suggested.) What sort of study would indeed be valid in getting us excited?

In principle it’s simple. You’d look at a very large number of people, accommodating differences in age and sex and race and whatever other characteristics you think might be relevant; you’d come up with an estimate of the initial biological age of each person in this investigation; and you’d follow up with frequent re-evaluations of their biological ages over a very long period of time. That way, for each person you’d be able to observe the rate at which their biological age changes; and for each group of people you’d be able to see whether and when their biological ages change at something other than a smooth rate. As I said, simple, at least in principle.

But what’s simple isn’t necessarily easy to actually carry out. And in fact it has proven to be remarkably difficult to do. The results cited are based on a tiny and limited study: 108 Californians aged 25-75, so, on average, two people at each chronological age; and they were followed, on average, for two years each. Not many people, not from around the world, not for very long. Not exactly definitive; in fact, barely a start. So I think these conclusions are at best an indicator of what future much larger studies should start to look at.

Would these conclusions apply, not just to a bunch of a hundred Californians, but also to people from, let’s say, South America, Australia, Japan (where people reach the highest chronological ages), Africa, etc etc? If it is found that there are still spikes in the ageing process, how much do the numbers differ across people? For example, if the first spike tends to occur somewhere between 34 and 44, what does that imply for the way we should try, as individuals, to deal with it? To what extent do lifestyle and environmental factors affect the spike ages? And so on. We know nothing about any of this.

It doesn’t matter that these conclusions from the study are now being widely cited as if they’re established fact. As you can infer from the way I’m saying all of this, I think those conclusions are fascinating, yes, but hardly facts. Experts are cited in the NY Times article as saying that the findings are “quite interesting, but I would say preliminary,” and they’re just “touching the surface” of how molecular changes relate to ageing. Exactly.

 

Don Ezra, now retired, is the former Co-Chairman of global consulting for Russell Investments worldwide, and the author of “Life Two: how to get to and enjoy what used to be called retirement”. This article is general information and does not consider the circumstances of any investor.

 

  •   14 May 2025
  • 2
  •      
  •   
2 Comments
DougC
May 15, 2025

Don, your comments on the California-108 study are well-founded. Two people in each age group for 2 years - the results are indicative of only the 2 people for 2 years and can hardly be extrapolated to wider populations.
Aging might not be invariable, but I suspect that genetics, diet and lifestyle combine to determine rates of aging that consequently differ quite a lot across wide population groups; and this will not be represented in cohorts of 2 people in each age group across 2 years.
For example, genetics. From personal experience, 3 generations ago 3 of my male ancestors married 3 sisters from the same family. All the members of that family and their direct descendants lived long and active lives – almost all into their 90’s and 2 past 100, my aunt (who resembled the females in that family a generation before) lived to 104. I only knew 3 in that cohort but they didn’t appear to have perceptibly aged suddenly around their 60’s – but possibly around their 90’s. I don’t know whether I have any of those genetics, but recently had to show my passport to prove I am over 70 and not to have to remove my shoes at an airport security check – I’m 82.
If the California-108 study had included some such ‘out-liers’ in their sample, the results might have been very different.

lyn
May 16, 2025

Don, time -frame for study of which you wrote, thought may be too short for scientific study of aging, made me think of Seven Up TV series started 1964 of 14 x 7yr olds followed up every 7 years, can't recall which was last one seen by me, quick google says series available, last one 2019 so they would have been 63, will watch to see if anything coincides, visible aging on screen/survival. Think originally commissioned for if 'class' born into makes difference. Longevity of women to fit 90+ in predominantly female family via all back to 1850's except for 1, like Doug below with interesting tale of 3 sisters, makes me feel it's genetic & sorted day of birth.

 

Leave a Comment:

RELATED ARTICLES

How long will you live?

‘Life expectancy’ – and why I don’t like the expression

Two months into retirement

banner

Most viewed in recent weeks

How to minimise tax with a will

Inheritance tax implications in Australia may surprise some, as poor estate planning without proper wills or trusts can lead to costly tax bills and delays for beneficiaries.

Testamentary trusts post-budget: Estate planning, tax reform and the ‘death tax’ debate

Proposed Budget changes to taxation are casting new uncertainty over testamentary trusts, prompting closer scrutiny of estate planning structures and the real implications of reforms still taking shape.

Meg on SMSFs: The CGT changes don’t impact super but what about Div 296 tax decisions?

New CGT rules could tip the scales in the super vs non-super debate. For those facing the Division 296 tax, the case for withdrawing has gotten more complex. A "comparison rate" tool may help assess decisions.

High quality businesses are on sale

Beneath the dominance of the ASX's largest stocks, much of the market has been left behind. High-quality companies are now trading at levels rarely seen, offering opportunities for investors willing to look deeper.

The investment mistake killing your returns

Retail investors face an increasingly complex product environment, but simplicity may be the most overlooked advantage in building a portfolio you can actually live with.

Welcome to Firstlinks Edition 667 with weekend update

The downfall of the giant and three lessons for investors.

  • 18 June 2026

Latest Updates

SMSF strategies

Meg on SMSFs: How wide is the ban on LRBAs?

The government's recent deal with the Greens has put SMSF property borrowing on the chopping block. The change raises tricky questions about timing, exceptions and what SMSFs will still be able to buy.

Shares

Why Australian shares are falling behind the world

Australia’s market boasts a long record of outperformance, but recent results tell a different story. Is the ASX’s lagging performance a temporary setback or evidence that structural forces will keep global markets ahead?

Taxation

The strange effect of the 30% minimum capital gains tax

The 30% minimum tax on capital gains sits at the heart of the budget's proposed reforms. Yet the mechanics reveal anomalies that introduce unexpected distortions that raise questions about its design.

Shares

The next phase of Australian equity leadership

For years, banks have powered Australian sharemarket returns. But changing economic conditions, stretched valuations and global trends suggest the next generation of winners may not be found in familiar domestic sectors.

Economy

Global market growth hinges on Iran War and AI rollout

Global growth is facing mounting pressure from war, higher oil prices, inflation and trade tensions. But a wave of AI-related investment may prove powerful enough to support economic activity and reshape the outlook for markets.

Retirement

The retirees who can't spend

Why do so many retirees pass away with their wealth intact? Conventional wisdom blames pension rules for the reluctance to spend, but a case study from New Zealand shows that the answer may not be as predictable.

Investment strategies

Here’s my investment philosophy. What’s yours?

Investors often hear they need an “investment philosophy,” yet few know what that really means. Beneath the jargon sits a simple idea: a handful of core beliefs that shape every financial decision, for better or worse.

Sponsors

Alliances

© 2026 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.